KK
AVDL

Kotler Kevin’s Avadel Pharmaceuticals AVDL Stock Holding History

Kotler Kevin’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$19M Buy
+879,400
New +$17.1M 4.43% 5

Other funds holding AVDL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.05% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kotler Kevin's AVDL Position: Q4 2025 in Review

Kotler Kevin opened a new position in Avadel Pharmaceuticals (AVDL) in Q4 2025: 741,343 shares worth $16M. The stake represents 3.74% of the portfolio and ranks #6 among its holdings.

207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

  • Kotler Kevin held 741,343 shares of Avadel Pharmaceuticals worth $16M as of Q4 2025.
  • Avadel Pharmaceuticals was a new Kotler Kevin position in Q4 2025.
  • Avadel Pharmaceuticals made up 3.74% of Kotler Kevin's portfolio in Q4 2025, its #6 holding.
  • 207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on Kotler Kevin's 13F filing for Q4 2025, filed 17 Feb 2026.